GM-CSF R alpha

GM-CSF R alpha

GM-CSF R alpha Informations sur la molécule

Molecule Name
Granulocyte-macrophage colony-stimulating factor receptor subunit alpha
Alias de la molécule
GM-CSF R alpha,GM-CSF-R-alpha,GMCSFR-alpha,GMR-alpha,CSF2RA,CSF2R,CSF2RY,CDw116,CD116
Drug Development Progress
Nombre de médicaments cliniques4
Nombre de médicaments commercialisés0
Phase de R&D la plus avancéePhase 3 Clinical
Alias de la cible
GM-CSF-R-alpha,GMCSFR-alpha,GMR-alpha,CD116,Colony Stimulating Factor 2 Receptor Subunit Alpha,Colony Stimulating Factor 2 Receptor, Alpha, Low-Affinity (Granulocyte-Macrophage),CSF2R,CSF2RAX,CSF2RAY,CSF2RX,CSF2RY,GM-CSF Receptor Alpha Subunit,GMCSFR,GMR,Granulocyte-Macrophage Colony-Stimulating Factor Receptor Alpha Chain,SMDP4,Colony Stimulating Factor 2 Receptor Alpha Subunit,CDw116,CD116 Antigen,Alpha-GM-CSF Receptor,AlphaGMR
Contexte de la molécule
GM-CSF R alpha(Granulocyte-macrophage colony-stimulating factor receptor subunit alpha) is also known as CSF2RA, CD116, GMR-alpha. Low affinity receptor for granulocyte-macrophage colony-stimulating factor. Transduces a signal that results in the proliferation, differentiation, and functional activation of hematopoietic cells. Hereditary pulmonary alveolar proteinosis (hPAP) is a rare disorder of pulmonary surfactant accumulation and hypoxemic respiratory failure caused by mutations in CSF2RA (encoding the granulocyte/macrophage colony-stimulating factor [GM-CSF] receptor α-chain [CD116]), which results in reduced GM-CSF-dependent pulmonary surfactant clearance by alveolar macrophages.

GM-CSF R alpha Liste de produits

No Data
You Have Viewed 0 Of 0 Results
  • 1

Can’t find what you need?

Submit your requirements and our technical
team will help.

Informations sur les médicaments cliniques

Nom anglaisCode de recherchePhase de R&DEntrepriseIndicationEssai clinique
MavrilimumabCAM-3001; KPL-301; GM-CSFR; CAM3001Phase 3 ClinicalCsl Ltd
Arthritis, Rheumatoid; Coronavirus Disease 2019 (COVID-19); Giant Cell Arteritis; Pneumonia
Details
Anti-GMR CAR T-cell TherapyPhase 2 ClinicalKyoto Prefectural University Of Medicine, Shinshu University School of Medicine
Leukemia, Myeloid, Acute; Leukemia, Myelomonocytic, Juvenile
Details
CSF2RA gene-corrected macrophages(University of South Florida)Phase 2 ClinicalRussian Academy Of Medical Sciences
Pulmonary Alveolar Proteinosis
Details
STSA-1005STSA-1005; STSA1005Phase 1 ClinicalStaidson(Beijing) Biopharmaceuticals Co Ltd
Coronavirus Disease 2019 (COVID-19)
Details